Alternatives to Adefovir If You Can't Fill Your Prescription

Adefovir dipivoxil (Hepsera) is an FDA-approved antiviral for chronic hepatitis B, but it is not always easy to find at local pharmacies. If you are struggling to fill your prescription, you may wonder whether there are effective alternatives. The good news: there are several well-established hepatitis B antivirals that are more widely available and, in many cases, considered more potent. But switching hepatitis B medications requires medical guidance — here is what you need to know.

Important Warning: Never Switch Hepatitis B Medications Without Your Doctor

Before reviewing alternatives, this point cannot be overstated: stopping adefovir abruptly — or switching to another medication without medical supervision — can cause a serious hepatitis B flare. Clinical trials showed that up to 25% of patients experienced significant liver enzyme elevations after discontinuing adefovir. Always consult your hepatologist, gastroenterologist, or infectious disease specialist before making any change to your hepatitis B regimen.

Why Is Adefovir No Longer the First-Line Choice?

When adefovir was approved by the FDA in 2002, it was a significant step forward for hepatitis B treatment. However, newer antivirals have largely replaced it as a first-line option because of several limitations:

Lower antiviral potency compared to entecavir and tenofovir

Risk of nephrotoxicity (kidney damage) with long-term use

Lower genetic barrier to resistance compared to entecavir and tenofovir

Only modest HBeAg seroconversion rates (approximately 12%)

Today, adefovir is primarily used in patients with lamivudine-resistant HBV (often in combination with lamivudine), patients who have specific contraindications to other agents, or in situations where other medications are not available. Current hepatitis B treatment guidelines from the American Association for the Study of Liver Diseases (AASLD) prioritize entecavir, tenofovir DF, and tenofovir alafenamide as first-line agents.

Alternative 1: Entecavir (Baraclude)

Entecavir is one of the most commonly prescribed hepatitis B antivirals and is widely stocked at most pharmacies. Key facts:

Available as: 0.5 mg and 1 mg tablets (the 1 mg dose is for lamivudine-experienced patients)

Antiviral potency: High — 68-90% of patients achieve undetectable HBV DNA after 48 weeks

Resistance: Very low in treatment-naive patients (high genetic barrier)

Nephrotoxicity: No known nephrotoxicity (advantage over adefovir and TDF)

Availability: Generic entecavir is widely stocked and less expensive than brand Baraclude

Note: Entecavir is less effective in patients who have already developed resistance to lamivudine. It is taken on an empty stomach (2 hours before or after a meal).

Alternative 2: Tenofovir Disoproxil Fumarate — TDF (Viread)

Tenofovir DF is a nucleotide analog closely related to adefovir and is one of the most potent hepatitis B antivirals available. Clinical trials showed TDF was significantly more effective than adefovir at suppressing HBV DNA — 93% viral suppression versus 63% for adefovir in HBeAg-negative patients.

Dose: 300 mg once daily

Active against lamivudine-resistant, adefovir-resistant, and entecavir-resistant HBV

Important: CANNOT be used concurrently with adefovir (additive nephrotoxicity risk)

Generic available, widely stocked at major pharmacies

39,333+ patients found their medications in stock

39K+

Find Adefovir In Stock Today →

Alternative 3: Tenofovir Alafenamide — TAF (Vemlidy)

Tenofovir alafenamide is a newer formulation of tenofovir with an improved safety profile, particularly for the kidneys and bones. It delivers tenofovir to liver cells more efficiently, allowing for a lower dose (25 mg vs 300 mg for TDF) with equivalent antiviral effect.

Better kidney and bone safety than TDF

Also CANNOT be used concurrently with adefovir (contraindicated)

Currently brand-name only (Vemlidy); more expensive than generic TDF

Alternative 4: Lamivudine (Epivir-HBV)

Lamivudine was one of the first oral antivirals approved for hepatitis B. It is inexpensive and widely available, but it has a major drawback: a high rate of viral resistance with long-term use (15-32% by 6 months). In fact, adefovir is commonly used specifically to treat patients whose HBV has become resistant to lamivudine. Lamivudine is generally only used in situations where newer options are not feasible.

Skip the calls, skip the stress.

Find Adefovir In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

How to Talk to Your Doctor About Switching

When speaking to your doctor about a possible switch, bring up:

Your current HBV DNA level and resistance history

Your kidney function (eGFR/creatinine) — important if considering TDF

Your insurance coverage and cost considerations

The specific difficulty you are having finding adefovir at local pharmacies

If you want to keep taking adefovir, medfinder can call pharmacies near you to find one that has it in stock — saving you the time of calling around yourself. Read: How to Find Adefovir in Stock Near You